RDNT RadNet, Inc.

FY2025 10-K
Filed: Mar 2, 2026
Health Care
Services-Medical LaboratoriesSEC EDGAR

RadNet, Inc. (RDNT) filed its fiscal year 2025 10-K annual report with the SEC on Mar 2, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Diagnostic imaging services revenue from patients and third-party payors under fee-for-service and capitation contracts
  • Emphasis on capitation arrangements earning per-enrollee monthly revenue for making imaging services available to health plan members
+3 more insights

Management Discussion & Analysis

  • Revenue $2.04B in 2025, up 11.5% YoY from $1.83B in 2024; Imaging Center revenue $1.99B up 10.9% YoY
  • Operating margin 3.0% in 2025 vs 5.7% in 2024; net income margin 0.8% in 2025 vs 2.0% in 2024
+4 more insights

Risk Factors

  • CMS 2026 Physician Fee Schedule final rule may reduce Medicare reimbursement rates and imaging volumes starting CY 2026
  • Significant exposure to California natural disasters: headquarters and 100+ centers vulnerable to wildfires, blackouts, earthquakes
+3 more insights

Financial Summary
XBRL

Revenue

$2.0B

Net Income

-$19M

Operating Margin

3.0%

Net Margin

-0.9%

ROE

-1.7%

Total Assets

$3.8B

EPS (Diluted)

$-0.25

Operating Cash Flow

$299M

Source: XBRL data from RadNet, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on RadNet, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available